| Rehab Services Of Nevada - Fallon | |
|
52 Commercial Way, Fallon, NV 89406-2600 | |
| (775) 867-3904 | |
| (775) 867-3901 |
| Full Name | Rehab Services Of Nevada - Fallon |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 52 Commercial Way, Fallon, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114097110 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rehab Services Of Nevada - Fallon 325 Hanson St, Winnemucca, NV 89445-3607 Ph: (775) 625-2222 | Rehab Services Of Nevada - Fallon 52 Commercial Way, Fallon, NV 89406-2600 Ph: (775) 867-3904 |
News Archive
A new study published on the preprint server bioRxiv in June 2020 shows that a candidate spike protein vaccine can induce neutralizing antibodies, antiviral T cell responses, and protection against infection.
A new study published in the American Journal of Transplantation reveals that since the elimination of the kidney allocation priority for matching for HLA-B on May 7, 2003, access to kidney transplantation for minorities has been improved. Improvement is a result of a policy that reduced the requirements for tissue matching.
The cornea is a transparent tissue lining the front of the eye, that is invisible tissue to the naked eye. It is a delicate tissue and disease or injury may lead to a loss of transparency or a change in the shape of the cornea, resulting in severe visual impairment.
The development of a wearable to detect early Alzheimer's and other neurodegenerative diseases years before symptoms show has taken a step closer to reality today, as UK charity Alzheimer's Research UK announces a partnership with Boston University that will see the first digital data flowing into its global Early Detection of Neurodegenerative diseases (EDoN) initiative.
IQ Therapeutics has completed the dosing of antibody IQNLF in a Phase I clinical trial. A total of 36 healthy volunteers participated in the randomized, placebo controlled, double blind, single dose-escalating study, intended to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of IQNLF.
› Verified 1 days ago
Kerry Susan Chicoine, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 52 Commercial Way, Fallon, NV 89406 Phone: 775-867-3904 Fax: 775-867-3904 | |
Steven E Louie, P.T. Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1680 W Williams Ave, Fallon, NV 89406 Phone: 775-867-3904 Fax: 775-867-3901 | |
Dr. Deborah Ruth Duarte, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 550 N Sherman St, Fallon, NV 89406 Phone: 888-366-0209 Fax: 775-423-7660 | |
Dominique French, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4050 Santa Fe Dr, Fallon, NV 89406 Phone: 847-815-3038 | |
Steven J Woodhouse, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 52 Commercial Way, Fallon, NV 89406 Phone: 775-867-3904 Fax: 775-867-3901 | |
Dr. Matthew Manalili, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2180 Reno Hwy, Fallon, NV 89406 Phone: 775-423-5233 Fax: 775-423-2101 |